SGHT: Sight Sciences Inc. Stocks News on November 17, 2025

New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans

SGHT

GlobeNewswire

6 days ago

New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans

How Recent Developments Are Changing The Sight Sciences Investment Story

SGHT

Simply Wall St.

9 days ago

How Recent Developments Are Changing The Sight Sciences Investment Story

SGHT

Zacks

11 days ago

Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

SGHT

Zacks

11 days ago

Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

SGHT

Motley Fool

11 days ago

Sight Sciences (SGHT) Q3 2025 Earnings Transcript

Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance

SGHT

GlobeNewswire

11 days ago

Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance

Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer

SGHT

GlobeNewswire

11 days ago

Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer

SGHT

GuruFocus.com

12 days ago

What To Expect From Sight Sciences Inc (SGHT) Q3 2025 Earnings

Sight Sciences to Present at Two Upcoming Investor Conferences

SGHT

GlobeNewswire

13 days ago

Sight Sciences to Present at Two Upcoming Investor Conferences

Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure

SGHT

GlobeNewswire

a month ago

Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure

3 Promising Penny Stocks With Market Caps Up To $300M

SGHT

Simply Wall St.

a month ago

3 Promising Penny Stocks With Market Caps Up To $300M

UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures

SGHT

Benzinga

2 months ago

UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures

SGHT

MT Newswires

2 months ago

Sight Sciences Says Omni Surgical System Gains UnitedHealthcare Coverage

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

SGHT

GlobeNewswire

2 months ago

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

Sight Sciences Leads The Pack Of 3 Promising Penny Stocks

SGHT

Simply Wall St.

5 months ago

Sight Sciences Leads The Pack Of 3 Promising Penny Stocks

SGHT

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 05/30/2025

Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential

SGHT

Simply Wall St.

6 months ago

Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential

Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th

SGHT

GlobeNewswire

6 months ago

Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th

SGHT

GuruFocus.com

6 months ago

Sight Sciences Inc (SGHT) Q1 2025 Earnings Call Highlights: Navigating Market Challenges and ...

SGHT

Zacks

6 months ago

Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

SGHT

Zacks

6 months ago

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

SGHT

GlobeNewswire

6 months ago

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

SGHT

GuruFocus.com

6 months ago

Sight Sciences Inc (SGHT) Q1 2025: Everything You Need To Know Ahead Of Earnings

Artivion (AORT) Lags Q1 Earnings Estimates

SGHT

Zacks

6 months ago

Artivion (AORT) Lags Q1 Earnings Estimates

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

SGHT

GlobeNewswire

7 months ago

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

Sight Sciences Announces the Release of its Sustainability Report

SGHT

GlobeNewswire

7 months ago

Sight Sciences Announces the Release of its Sustainability Report

Sight Sciences Appoints Gary Burbach to its Board of Directors

SGHT

GlobeNewswire

7 months ago

Sight Sciences Appoints Gary Burbach to its Board of Directors

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

SGHT

GlobeNewswire

7 months ago

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

SGHT

Simply Wall St.

7 months ago

April 2025's Top Penny Stocks To Watch

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

SGHT

GlobeNewswire

8 months ago

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

SGHT

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Sight Sciences Inc Earnings Call

SGHT

GuruFocus.com

8 months ago

Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Challenges

SGHT

Zacks

8 months ago

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics

SGHT

Zacks

8 months ago

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

SGHT

GlobeNewswire

8 months ago

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

SGHT

GuruFocus.com

8 months ago

Earnings To Watch: Sight Sciences Inc (SGHT) Reports Q4 2024 Result

March 2025 Penny Stocks To Consider For Growth

SGHT

Simply Wall St.

8 months ago

March 2025 Penny Stocks To Consider For Growth

SGHT

Zacks

9 months ago

Will Sight Sciences, Inc. (SGHT) Report Negative Earnings Next Week? What You Should Know

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

SGHT

GlobeNewswire

9 months ago

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

SGHT

GlobeNewswire

9 months ago

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day

SGHT

GlobeNewswire

9 months ago

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day

SGHT

MT Newswires

10 months ago

UBS Adjusts Price Target on Sight Sciences to $5 From $5.50, Keeps Buy Rating

Promising US Penny Stocks To Consider In January 2025

SGHT

Simply Wall St.

10 months ago

Promising US Penny Stocks To Consider In January 2025

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

SGHT

GlobeNewswire

10 months ago

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

SGHT

MT Newswires

10 months ago

Sight Sciences Reports Positive OMNI Surgical System Data From 36-Month Study

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

SGHT

GlobeNewswire

10 months ago

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

SGHT

MT Newswires

a year ago

Sight Sciences' TearCare Treatment for Dry Eye Disease to Generate Cost Savings Versus Existing Prescribed Medications

Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options

Sight Sciences initiated with a Buy at UBS

SGHT

TipRanks

a year ago

Sight Sciences initiated with a Buy at UBS

SGHT

MT Newswires

a year ago

UBS Initiates Sight Sciences at Buy With $5.50 Price Target

SGHT

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 12/06/2024

SGHT

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 12/04/2024

Nano Dimension Leads 3 US Penny Stocks To Consider

SGHT

Simply Wall St.

a year ago

Nano Dimension Leads 3 US Penny Stocks To Consider

Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference

SGHT

GlobeNewswire

a year ago

Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference

Inside a $400 billion bet on the brain-computer interface revolution

SGHT

Yahoo Finance

a year ago

Inside a $400 billion bet on the brain-computer interface revolution

Sight Sciences price target lowered to $5 from $7 at Morgan Stanley

SGHT

TipRanks

a year ago

Sight Sciences price target lowered to $5 from $7 at Morgan Stanley

Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

SGHT

Simply Wall St.

a year ago

Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

SGHT

GuruFocus.com

a year ago

Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...

SGHT

Zacks

a year ago

Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates

Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance

SGHT

GlobeNewswire

a year ago

Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance

Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

SGHT

GlobeNewswire

a year ago

Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

SGHT

GuruFocus.com

a year ago

Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect

Integer (ITGR) Q3 Earnings Surpass Estimates

SGHT

Zacks

a year ago

Integer (ITGR) Q3 Earnings Surpass Estimates

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

SGHT

GlobeNewswire

a year ago

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

SGHT

MT Newswires

a year ago

Sight Sciences' TearCare Treatment Improves Symptoms of Dry Eye Disease in Trial

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

SGHT

GlobeNewswire

a year ago

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

SGHT

Simply Wall St.

a year ago

Institutional investors own a significant stake of 34% in Sight Sciences, Inc. (NASDAQ:SGHT)

AmEx downgraded, Texas Instruments upgraded: Wall Street's top analyst calls

SGHT

The Fly

a year ago

AmEx downgraded, Texas Instruments upgraded: Wall Street's top analyst calls

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

SGHT

GlobeNewswire

a year ago

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

SGHT

Thomson Reuters StreetEvents

a year ago

Q2 2024 Sight Sciences Inc Earnings Call

SGHT

Zacks

a year ago

Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates

Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance

SGHT

GlobeNewswire

a year ago

Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance

Integer (ITGR) Q2 Earnings Surpass Estimates

SGHT

Zacks

a year ago

Integer (ITGR) Q2 Earnings Surpass Estimates

Sight Sciences to Report Second Quarter Financial Results on August 1, 2024

SGHT

GlobeNewswire

a year ago

Sight Sciences to Report Second Quarter Financial Results on August 1, 2024

One Sight Sciences Insider Raised Stake By 34% In Previous Year

SGHT

Simply Wall St.

a year ago

One Sight Sciences Insider Raised Stake By 34% In Previous Year

Sight Sciences Announces the Release of its First Sustainability Report

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces the Release of its First Sustainability Report

SGHT

MT Newswires

a year ago

Sight Sciences Trial Results Show Improved Dry Eye Disease Signs, Symptoms for TearCare Patients Crossed Over From Restasis

Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis

Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma

Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference

SGHT

GlobeNewswire

2 years ago

Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference

SGHT

Insider Monkey

2 years ago

Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2024 Earnings Call Transcript

Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

SGHT

Simply Wall St.

2 years ago

Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

SGHT

MT Newswires

2 years ago

Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed

SGHT

Thomson Reuters StreetEvents

2 years ago

Q1 2024 Sight Sciences Inc Earnings Call

SGHT

Zacks

2 years ago

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance

SGHT

GlobeNewswire

2 years ago

Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance

Sight Sciences awarded $34m in Alcon patent infringement case

SGHT

Medical Device Network

2 years ago

Sight Sciences awarded $34m in Alcon patent infringement case

SGHT

MT Newswires

2 years ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

SGHT

MT Newswires

2 years ago

Sector Update: Health Care Stocks Rise in Monday Afternoon Trading

SGHT

MT Newswires

2 years ago

Update: Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump

SGHT

MT Newswires

2 years ago

Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

SGHT

GlobeNewswire

2 years ago

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

SGHT

Simply Wall St.

2 years ago

With 34% ownership, Sight Sciences, Inc. (NASDAQ:SGHT) has piqued the interest of institutional investors

Sight Sciences to Report First Quarter Financial Results on May 2, 2024

SGHT

GlobeNewswire

2 years ago

Sight Sciences to Report First Quarter Financial Results on May 2, 2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

SGHT

GlobeNewswire

2 years ago

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

$Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting$

SGHT

GlobeNewswire

2 years ago

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference

SGHT

GlobeNewswire

2 years ago

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference

SGHT

Insider Monkey

2 years ago

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2023 Earnings Call Transcript

SGHT

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Sight Sciences Inc Earnings Call

SGHT

GuruFocus.com

2 years ago

Latest Sight Sciences Inc. (SGHT) News on November 17, 2025

Share on Social Networks: